Fidelity International’s ProQR Therapeutics PRQR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-899,257
Closed -$669K 862
2022
Q3
$669K Sell
899,257
-158,834
-15% -$118K ﹤0.01% 736
2022
Q2
$823K Sell
1,058,091
-47,002
-4% -$36.6K ﹤0.01% 730
2022
Q1
$1M Buy
1,105,093
+81,268
+8% +$73.5K ﹤0.01% 735
2021
Q4
$8.2M Sell
1,023,825
-181,935
-15% -$1.46M 0.01% 558
2021
Q3
$10.1M Buy
1,205,760
+177,958
+17% +$1.49M 0.01% 535
2021
Q2
$6.93M Buy
1,027,802
+370,340
+56% +$2.5M 0.01% 601
2021
Q1
$4.35M Buy
657,462
+326,258
+99% +$2.16M ﹤0.01% 623
2020
Q4
$1.39M Hold
331,204
﹤0.01% 630
2020
Q3
$1.59M Buy
331,204
+139,590
+73% +$668K ﹤0.01% 605
2020
Q2
$1.17M Buy
191,614
+112,372
+142% +$683K ﹤0.01% 603
2020
Q1
$435K Buy
79,242
+27,018
+52% +$148K ﹤0.01% 630
2019
Q4
$518K Buy
52,224
+12,009
+30% +$119K ﹤0.01% 672
2019
Q3
$232K Buy
+40,215
New +$232K ﹤0.01% 668